Target Price | $304.38 |
Price | $284.82 |
Potential | 6.87% |
Number of Estimates | 41 |
41 Analysts have issued a price target Tesla 2026 . The average Tesla target price is $304.38. This is 6.87% higher than the current stock price. The highest price target is $470.00 65.02% , the lowest is $115.00 59.62% . | |
A rating was issued by 57 analysts: 30 Analysts recommend Tesla to buy, 15 to hold and 12 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Tesla stock has an average upside potential 2026 of 6.87% . Most analysts recommend the Tesla stock at Purchase. |
48 Analysts have issued a sales forecast Tesla 2025 . The average Tesla sales estimate is $98.5b . This is 2.89% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $126b 31.26% , the lowest is $80.4b 15.99% .
This results in the following potential growth metrics:
2024 | $97.7b | 0.95% |
---|---|---|
2025 | $98.5b | 0.82% |
2026 | $120b | 21.69% |
2027 | $146b | 21.64% |
2028 | $171b | 17.52% |
2029 | $214b | 24.68% |
34 Analysts have issued an Tesla EBITDA forecast 2025. The average Tesla EBITDA estimate is $13.8b . This is 9.40% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $18.7b 47.80% , the lowest is $8.2b 35.02% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $13.1b | 3.17% |
---|---|---|
2025 | $13.8b | 5.43% |
2026 | $18.5b | 34.00% |
2027 | $25.8b | 38.88% |
2028 | $31.3b | 21.50% |
2029 | $41.7b | 33.11% |
2024 | 13.44% | 4.08% |
---|---|---|
2025 | 14.05% | 4.55% |
2026 | 15.47% | 10.11% |
2027 | 17.67% | 14.22% |
2028 | 18.26% | 3.34% |
2029 | 19.50% | 6.79% |
27 Tesla Analysts have issued a net profit forecast 2025. The average Tesla net profit estimate is $5.2b . This is 11.21% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $9.7b 65.38% , the lowest is $2.4b 59.34% .
This results in the following potential growth metrics and future Net Margins:
2024 | $6.6b | 52.56% |
---|---|---|
2025 | $5.2b | 20.79% |
2026 | $8.5b | 64.18% |
2027 | $11.2b | 30.58% |
2028 | $16.9b | 51.60% |
2029 | $23.1b | 36.88% |
2024 | 6.72% | 53.00% |
---|---|---|
2025 | 5.28% | 21.48% |
2026 | 7.13% | 35.04% |
2027 | 7.65% | 7.29% |
2028 | 9.87% | 29.02% |
2029 | 10.84% | 9.83% |
27 Analysts have issued a Tesla forecast for earnings per share. The average Tesla EPS is $1.62 . This is 10.99% lower than earnings per share in the financial year 2024. The highest EPS forecast is $3.01 65.38% , the lowest is $0.74 59.34% .
This results in the following potential growth metrics and future valuations:
2024 | $2.04 | 52.56% |
---|---|---|
2025 | $1.62 | 20.59% |
2026 | $2.65 | 63.58% |
2027 | $3.46 | 30.57% |
2028 | $5.25 | 51.73% |
2029 | $7.19 | 36.95% |
Current | 156.63 | 238.29% |
---|---|---|
2025 | 176.26 | 12.53% |
2026 | 107.36 | 39.09% |
2027 | 82.22 | 23.42% |
2028 | 54.23 | 34.04% |
2029 | 39.62 | 26.94% |
Based on analysts' sales estimates for 2025, the Tesla stock is valued at an EV/Sales of 9.06 and an P/S ratio of 9.30 .
This results in the following potential growth metrics and future valuations:
Current | 9.32 | 57.43% |
---|---|---|
2025 | 9.06 | 2.76% |
2026 | 7.45 | 17.83% |
2027 | 6.12 | 17.79% |
2028 | 5.21 | 14.91% |
2029 | 4.18 | 19.79% |
Current | 9.57 | 56.92% |
---|---|---|
2025 | 9.30 | 2.81% |
2026 | 7.64 | 17.83% |
2027 | 6.28 | 17.79% |
2028 | 5.35 | 14.91% |
2029 | 4.29 | 19.79% |
Analyst | Rating | Action | Date |
---|---|---|---|
Wedbush |
Outperform
➜
Outperform
|
Unchanged | May 01 2025 |
Stifel |
Buy
➜
Buy
|
Unchanged | Apr 24 2025 |
Guggenheim |
Sell
➜
Sell
|
Unchanged | Apr 24 2025 |
Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Apr 23 2025 |
Canaccord Genuity |
Buy
➜
Buy
|
Unchanged | Apr 23 2025 |
Benchmark |
Buy
➜
Buy
|
Unchanged | Apr 23 2025 |
GLJ Research |
Sell
➜
Sell
|
Unchanged | Apr 23 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Wedbush:
Outperform
➜
Outperform
|
May 01 2025 |
Unchanged
Stifel:
Buy
➜
Buy
|
Apr 24 2025 |
Unchanged
Guggenheim:
Sell
➜
Sell
|
Apr 24 2025 |
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Apr 23 2025 |
Unchanged
Canaccord Genuity:
Buy
➜
Buy
|
Apr 23 2025 |
Unchanged
Benchmark:
Buy
➜
Buy
|
Apr 23 2025 |
Unchanged
GLJ Research:
Sell
➜
Sell
|
Apr 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.